Clinical Trial Update: A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab [Phase 2]

View source ↗

Summary

Phase II trial of standard chemoradiation with add-on cetuximab in advanced head and neck cancers has completed, evaluating cetuximab in oropharyngeal, hypophar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Oropharyngeal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: University of Zurich | Conditions: Oropharyngeal Cancer, Hypopharyngeal Cancer | Phase 2 | Status: COMPLETED